McGlinn Cancer Institute, Reading Hospital

West Reading, Pennsylvania 19611

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Melanoma

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients — Stopped early